Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Cancers
Volume 9, Issue 12, Pages 43
Publisher
MDPI AG
Online
2017-05-05
DOI
10.3390/cancers9050043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials
- (2017) Masatoshi Kudo ONCOLOGY
- AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
- (2017) Michael Schweizer et al. Cancers
- Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
- (2016) M. Ikeda et al. ANNALS OF ONCOLOGY
- Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals
- (2016) Liang Shi et al. CANCER LETTERS
- Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study
- (2016) Michael Bitzer et al. JOURNAL OF HEPATOLOGY
- Targeting Androgen Receptor (AR)->IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression
- (2016) L. Shi et al. MOLECULAR CANCER THERAPEUTICS
- High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth
- (2016) Adam T. Szafran et al. PROSTATE
- Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma
- (2016) Lupin Jiang et al. Oncotarget
- Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells
- (2016) Hsueh-Chou Lai et al. Oncotarget
- The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals
- (2016) Junjie Xu et al. EBioMedicine
- Sorafenib Action in Hepatitis B Virus X–Activated Oncogenic Androgen Pathway in Liver through SHP-1
- (2015) Sheng-Han Wang et al. JNCI-Journal of the National Cancer Institute
- Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1
- (2015) D C Koch et al. ONCOGENE
- Sorafenib Action in Hepatitis B Virus X–Activated Oncogenic Androgen Pathway in Liver through SHP-1
- (2015) Sheng-Han Wang et al. JNCI-Journal of the National Cancer Institute
- Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
- (2014) Wen-Lung Ma et al. ENDOCRINE-RELATED CANCER
- Involvement of androgen receptor and glucose-regulated protein 78kDa in human hepatocarcinogenesis
- (2014) Xia Jiang et al. EXPERIMENTAL CELL RESEARCH
- Identification of Androgen Receptor Splice Variant Transcripts in Breast Cancer Cell Lines and Human Tissues
- (2014) Dong Gui Hu et al. Hormones & Cancer
- Androgen Receptor Gene Rearrangements: New Perspectives on Prostate Cancer Progression
- (2013) Lucas J. Brand et al. CURRENT DRUG TARGETS
- Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
- (2012) Su Jung Oh et al. ENDOCRINE-RELATED CANCER
- Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis
- (2012) Wen-Lung Ma et al. HEPATOLOGY
- Androgen Receptor Promotes Hepatitis B Virus-Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription
- (2010) M. H. Wu et al. Science Translational Medicine
- Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3β kinase pathways
- (2009) Wan-Jen Yang et al. HEPATOLOGY
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling
- (2008) T. Kanda et al. JOURNAL OF VIROLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started